Gremlin promotes vascular smooth muscle cell proliferation and migration

被引:43
作者
Maciel, Thiago T. [1 ,2 ]
Melo, Rosilene S. [1 ]
Schor, Nestor [1 ]
Campos, Alexandre H. [1 ,2 ]
机构
[1] Univ Fed Sao Paulo, Div Nephrol, BR-04023900 Sao Paulo, Brazil
[2] Albert Einstein Res & Educ Inst, Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
gremlin; bone morphogenetic proteins; vascular smooth muscle cell; proliferation; restenosis;
D O I
10.1016/j.yjmcc.2007.10.021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recent reports highlight the importance of BMP in the vasculature. We investigated the expression pattern and role of the BNIP antagonist gremlin in VSMC. We detected gremlin mRNA constitutive expression in adult and embryonic rat aortic VSMC, and in rat carotids. In vitro analysis demonstrated that angiotensin II, TGF-beta 1 and PDGF induced significant changes in gremlin mRNA expression. Gremlin stable overexpression in A7r5 cells blocked BMP signaling. BMP-mduced reduction in VSMC DNA synthesis was markedly inhibited by gremlin overexpression. In fact, gremlin overexpression increased DNA synthesis and cell counts, and accelerated cell cycle progression of VSMC, through mechanisms that include p27(kip1) down-regulation. Gremlin also led to marked increments in VSMC migration. In addition, gremlin gene silencing promoted a significant blockade on cell proliferation and migration. In vivo studies disclosed increased gremlin protein expression in the neointima of balloon-injured carotid arteries. In summary, the BMP antagonist gremlin is constitutively expressed in the normal vasculature. Gremlin induces VSMC proliferation and migration and is significantly regulated by growth factors and injury. We postulate that gremlin plays a part in the development of pathological phenotypic changes of adult VSMC. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:370 / 379
页数:10
相关论文
共 44 条
[1]   Extracellular regulation of BMP signaling in vertebrates: A cocktail of modulators [J].
Balemans, W ;
Van Hul, W .
DEVELOPMENTAL BIOLOGY, 2002, 250 (02) :231-250
[2]   Drm/Gremlin transcriptionally activates p21Cip1 via a novel mechanism and inhibits neoplastic transformation [J].
Chen, B ;
Athanasiou, M ;
Gu, QP ;
Blair, DG .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 295 (05) :1135-1141
[3]  
CHEN B, J IMMUNOL, V173, P914
[4]   Bone morphogenetic proteins [J].
Chen, D ;
Zhao, M ;
Mundy, GR .
GROWTH FACTORS, 2004, 22 (04) :233-241
[5]   Smad-dependent and Smad-independent pathways in TGF-β family signalling [J].
Derynck, R ;
Zhang, YE .
NATURE, 2003, 425 (6958) :577-584
[6]   Expression of gremlin, a bone morphogenetic protein antagonist, in human diabetic nephropathy [J].
Dolan, V ;
Murphy, M ;
Sadlier, D ;
Lappin, D ;
Doran, P ;
Godson, C ;
Martin, F ;
O'Meara, Y ;
Schmid, H ;
Henger, A ;
Kretzler, M ;
Droguett, A ;
Mezzano, S ;
Brady, HR .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 45 (06) :1034-1039
[7]  
Dorai H, 2000, J CELL PHYSIOL, V184, P37, DOI 10.1002/(SICI)1097-4652(200007)184:1<37::AID-JCP4>3.0.CO
[8]  
2-M
[9]  
Franzén Å, 2001, BIOCHEM BIOPH RES CO, V285, P773
[10]   Bone morphogenetic proteins and their antagonists [J].
Gazzerro, Elisabetta ;
Canalis, Ernesto .
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2006, 7 (1-2) :51-65